Please wait while the formulary information is being retrieved.
DESOXYN (METHAMPHETAMINE HCL)
- Attention-deficit hyperactivity disorder
methamphetamine 5 mg tablet
- Dosage information is not available
5 mg tablet
- Dosage information is not available
- isocarboxazid
- Marplan
- Matulane
- methylene blue (antidote)
- Nardil
- Parnate
- phenelzine
- procarbazine
- tranylcypromine
Contraindicated
- amitriptyline
- amitriptyline-chlordiazepoxide
- amoxapine
- Amrix
- Anafranil
- Azilect
- bromocriptine
- cabergoline
- Cafergot
- clomipramine
- Compound 347
- cyclobenzaprine
- cyclobenzaprine with msm
- Cycloset
- D.h.e.45
- Datscan
- desipramine
- dihydroergotamine
- doxepin
- Eldepryl
- enflurane
- ergoloid
- Ergomar
- ergotamine tartrate
- ergotamine-caffeine
- Forane
- imipramine HCl
- imipramine pamoate
- ioflupane I 123
- isoflurane
- linezolid
- maprotiline
- methylergonovine
- Migergot
- Migranal
- Norpramin
- nortriptyline
- Pamelor
- Parlodel
- perphenazine-amitriptyline
- protriptyline
- Prudoxin
- rasagiline
- selegiline HCl
- sevoflurane
- Silenor
- Sojourn
- Surmontil
- Tabradol
- Terrell
- Tofranil
- Tofranil-pm
- trimipramine
- Ultane
- Vivactil
- Zelapar
- Zonalon
- Zyvox
Severe
Moderate
- acetazolamide
- acetazolamide sodium
- Al hyd-Mg tr-alg ac-sod bicarb
- Alka-seltzer
- Alka-seltzer Extra Strength
- Alka-seltzer Gold
- Alka-seltzer Heartburn
- Alka-seltzer Original
- Alka-seltzer Pm
- Antacid & Pain Relief
- Antacid Tablet
- aspirin-diphenhydramine
- aspirin-sod bicarb-citric acid
- Brisdelle
- Cardiolite
- Celexa
- Ceralyte-70
- Ceraors 75
- Cerasport
- Cerasport Ex1
- citalopram
- Cymbalta
- Cytra K Crystals
- Cytra-2
- Cytra-3
- Cytra-k
- desvenlafaxine
- desvenlafaxine fumarate
- desvenlafaxine succinate
- Diamox Sequels
- DM-GG-potassium citrate
- duloxetine
- E-z-gas Ii
- Efferves Pain Relief Antacid
- Effervescent Antacid
- Effervescent Pain Relief
- Effervescent Pain Reliever
- Effexor Xr
- escitalopram oxalate
- Fetzima
- fluoxetine
- fluvoxamine
- Foaming Antacid
- Gaviscon
- Gripe Water
- Khedezla
- kit for Tc 99m-sestamibi no.1
- levomilnacipran
- Lexapro
- Luvox Cr
- Medi-seltzer
- methazolamide
- milnacipran
- Neptazane
- Neut
- olanzapine-fluoxetine
- omeprazole-sodium bicarbonate
- Oracit
- paroxetine HCl
- paroxetine mesylate
- Paxil
- Paxil Cr
- PEG 3350-bowel 2,two part prep
- Pexeva
- pot & sod citrate-citric acid
- potassium citrate
- potassium citrate-citric acid
- Pristiq
- Prozac
- Prozac Weekly
- Sarafem
- Savella
- sertraline
- sod & pot chlorid-sod cit-rice
- sod bic-ginger-fennel-chamom
- sod bicarb-citric ac-simeth
- sodium & potassium bicarbonate
- sodium acetate
- sodium bicarb & citrate
- sodium bicarbonate
- sodium citrate-citric acid
- sodium lactate
- Sorbutuss
- Suclear
- Symbyax
- Taron-crystals
- Tham
- Theralith Xr
- Tricitrates
- tromethamine
- Urocit-k 10
- Urocit-k 15
- Urocit-k 5
- venlafaxine
- Viibryd
- vilazodone
- vit B6-mag cit & ox-potass cit
- Zegerid
- Zegerid Otc
- Zoloft
- Acute myocardial infarction
- Cardiac arrhythmia
- Cardiomyopathy
- Chronic kidney disease stage 5 (failure) GFr<15 ml/min
- Congenital long QT syndrome
- Coronary artery disease
- Glaucoma
- Hyperthyroidism
- Lactating mother
- Severe arteriosclerotic vascular disease
- Structural disorder of heart
Contraindicated
- Anorexia
- Bipolar disorder
- Cerebrovascular accident
- Chronic heart failure
- Chronic kidney disease stage 4 (severe) GFR 15-29 ml/min
- Drug abuse
- Gilles de la tourette syndrome
- Hypertension
- Increased cardiovascular event risk
- Manic disorder
- Motor tic disorder
- Psychotic disorder
- Raynaud's phenomenon
- Seizure disorder
- Suicidal ideation
Severe
Moderate
- Aggressive behavior
- Kidney disease with likely reduction in GFR
- Weight loss
DESOXYN (METHAMPHETAMINE HCL)
- Attention-deficit hyperactivity disorder
- None
- Anorexia
- False sense of well-being
- Insomnia
- Irritability
- Nausea
- Nervousness
- Symptoms of anxiety
- Upper abdominal pain
- Vomiting
More Frequent
Severe
Less Severe
- Hypersensitivity drug reaction
- Abnormal sexual function
- Agitation
- Constipation
- Diarrhea
- Dizziness
- Drowsy
- Dysgeusia
- Dyspnea
- Erectile dysfunction
- Fatigue
- Fever
- General weakness
- Headache disorder
- Hostility
- Hyperhidrosis
- Libido changes
- Palpitations
- Skin rash
- Tachycardia
- Tremor
- Urinary tract infection
- Urticaria
- Weight loss
- Xerostomia
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Acute myocardial infarction
- Anaphylaxis
- Angioedema
- Cardiac arrhythmia
- Cerebrovascular accident
- Drug-induced psychosis
- Exacerbation of gilles de la tourette's syndrome
- Hallucinations
- Hepatitis
- Hypertension
- Priapism
- Rhabdomyolysis
- Seizure disorder
- Stevens-johnson syndrome
- Suicidal ideation
- Toxic epidermal necrolysis
Less Severe
- Accommodation disorder
- Aggressive behavior
- Alopecia
- Altered mental status
- Blurred vision
- Bruxism
- Chest pain
- Depression
- Diplopia
- Drug dependence
- Dyskinesia
- Dysphoric mood
- Euphoria
- Excoriation disorder
- Frequent erections
- Logorrhea
- Manic disorder
- Mood changes
- Motor tic disorder
- Mydriasis
- Paresthesia
- Peripheral vasoconstriction
- Raynaud's phenomenon
- Syncope
Contraindicated
None
Severe Precaution
Methamphetamine
Not indicated age < 6 years. Risks associated with cardiac structural defects. May affect growth rate and behavior.
- 1 Day – 6 Years
- Not indicated age < 6 years. Risks associated with cardiac structural defects. May affect growth rate and behavior.
Management or Monitoring Precaution
Methamphetamine Hydrochloride
Warning with use in cardiac structural defects. Monitor growth and behavior.
- 6 Years – 18 Years
- Warning with use in cardiac structural defects. Monitor growth and behavior.
Methamphetamine Hydrochloride
- Severity Level:
C
- Additional Notes: Potential withdrawal symptoms in neonate including agitation, listlessness
Contraindicated
Methamphetamine Hydrochloride
Amphetamine concentrated in milk;May cause irritability,poor sleeping pattern
| General | Excretion Potential | Effect on Infant | Notes |
| Drug should not be given to breast feeding mothers | Excreted | Not known; no or inclusive data | Amphetamine concentrated in milk;May cause irritability,poor sleeping pattern |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Amphetamines
Neuro/Psych-May exacerbate pre-existing insomnia. Cardiovascular-May exacerbate pre-existing coronary insufficiency, cause or exacerbate peripheral vasculopathy. Gastrointestinal-Anorexia may cause significant weight loss.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | N | N | Y | Y | N | N |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- Misuse or abuse of amphetamines may result in serious (possibly fatal) heart and blood pressure problems. Amphetamine-type medications can be habit-forming. Use only as directed.<br /><br />With long-term use, drug dependence may occur, which may cause withdrawal symptoms after stopping the drug. For weight loss, this medication should not be used long-term (more than a few weeks) and should only be used when other treatments have failed. Consult your doctor or pharmacist for more details.
| Attention-deficit hyperactivity disorder | |
| F90 | Attention-deficit hyperactivity disorders |
| F90.0 | Attention-deficit hyperactivity disorder, predominantly inattentive type |
| F90.1 | Attention-deficit hyperactivity disorder, predominantly hyperactive type |
| F90.2 | Attention-deficit hyperactivity disorder, combined type |
| F90.8 | Attention-deficit hyperactivity disorder, other type |
| F90.9 | Attention-deficit hyperactivity disorder, unspecified type |
| 0-9 | A-Z |
|---|---|
| F90 | Attention-deficit hyperactivity disorders |
| F90.0 | Attention-deficit hyperactivity disorder, predominantly inattentive type |
| F90.1 | Attention-deficit hyperactivity disorder, predominantly hyperactive type |
| F90.2 | Attention-deficit hyperactivity disorder, combined type |
| F90.8 | Attention-deficit hyperactivity disorder, other type |
| F90.9 | Attention-deficit hyperactivity disorder, unspecified type |
Formulary Reference Tool